Guangzhou Baxter Qiaoguang Healthcare Co., Ltd. is a joint venture between Baxter (China) Investment Co., Ltd. and Guangzhou Baiyunshan Pharmaceutical Co. Ltd., a subsidiary of GPC. The joint venture produces and develops parenteral nutrition products and committed to becoming the leading company in parenteral nutrition industry in China.

Baxter Qiaoguang, a specific manufacturer for parenteral nutrition products, is devoted to providing patients with high-quality products and services and raise awareness of parenteral nutrition.

Its major products include:

- Medium and Long Chain Fat Emulsion Injection C8-24) (侨光卡路®)

- Long Chain Fat Emulsion Injection (OO) (ClinOleic®)

- Long Chain Fat Emulsion Injection C14-24 (卡里®)

- Lipid emulsion 10% / 15 L-amino acids / glucose 20% (Clinomel®)

- Multivitamins for Infusion (12) (Cernevit®)

- Compound Amino Acid Injection (15AA) (肝安®)

Honors

2008-2014 “Enterprise in Compliance with Contracts and with Integrity in Guangdong Province” issued by Guangzhou Administration for Industry and Commerce for six times

2011 & 2012 “Cleaner Production Enterprise in Guangzhou” issued by Guangzhou Environmental Protection Bureau

2012 “A-level Taxpayer 2010-2011” issued by Liwan District Government, Guangzhou

2012 Enterprise with Occupational Safety and Health Management System

2014 “Company with A-level Credit in Chemicals and Pharmaceuticals Industry” issued by China Pharmaceutical Industry Association